Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 6, 2022; 10(19): 6399-6405
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6399
Table 1 Comparison of baseline information between infected and controlled groups, n (%)
Factor
Infected group (n = 67)
Control group (n = 70)
t2 value
P value
Age (yr)52.3 ± 8.051.5 ± 7.30.612 0.542
Fracture to surgery interval (d)13.2 ± 4.112.0 ± 4.81.570 0.119
Gender0.821 0.365
Man38 (56.72)45 (64.29)
Woman29 (43.28)25 (35.71)
Ruedi-Allgower typing6.295 0.012
Type II36 (53.73)52 (74.29)
Type III31 (46.27)18 (25.71)
Wound contamination9.260 0.002
Yes26 (38.81)11 (15.71)
No41 (61.19)59 (84.29)
Surgical approach2.603 0.107
Early open reduction54 (80.6)48 (68.57)
Step delay surgery13 (19.4)22 (31.43)
Surgical incision type5.952 0.015
I-II51 (76.12)64 (91.43)
III16 (23.88)6 (8.57)
Antibiotics administered postoperatively3.088 0.079
Yes47 (70.15)58 (82.86)
No20 (29.85)12 (17.14)
Diabetes6.518 0.011
Yes12 (17.91)3 (4.29)
No55 (82.09)67 (95.71)
Hypertension1.476 0.224
Yes9 (13.43)5 (7.14)
No58 (86.57)65 (92.86)
Table 2 Multivariate analysis
Parameter

SE
Walds
P value
OR
95%CI
Ruedi-Allgower fracture type0.711 0.310 5.260 0.0382.036 1.109-3.738
Wound contamination0.824 0.257 10.280 02.280 1.378-3.772
Surgical incision type0.610 0.228 7.158 0.0061.840 1.177-2.877
Diabetes1.162 0.496 5.488 0.0343.196 1.209-8.450
Constant term0.944 0.628 2.260 0.2192.570 0.751-8.801